% HPV positive at enrollment | % HPV negative at enrollment | % Cumulative HPV incidence#12 months | % Cumulative HPV incidence 24 months | % Cumulative HPV incidence end of follow-up^ | |
---|---|---|---|---|---|
HR-HPV | 25.3 | 74.7 | 29.4 | 43.0 | 51.3 |
LR-HPV | 21.8 | 78.2 | 31.7 | 47.4 | 54.3 |
HPV16 | 7.1 | 92.9 | 5.7 | 9.8 | 12.4 |
HPV18 | 2.5 | 97.5 | 3.5 | 6.3 | 8.2 |
HPV31 | 3.8 | 96.2 | 4.7 | 8.0 | 10.5 |
HPV33 | 1.0 | 99.0 | 1.7 | 3.1 | 3.8 |
HPV35 | 1.3 | 98.7 | 2.4 | 3.6 | 4.8 |
HPV39 | 3.2 | 96.8 | 3.7 | 6.1 | 8.3 |
HPV45 | 1.7 | 98.3 | 3.0 | 5.3 | 6.5 |
HPV51 | 4.2 | 95.8 | 6.1 | 10.8 | 13.6 |
HPV52 | 5.1 | 94.9 | 6.3 | 12.1 | 15.4 |
HPV56 | 3.2 | 96.8 | 4.0 | 7.5 | 9.8 |
HPV58 | 2.4 | 97.6 | 3.6 | 6.0 | 7.8 |
HPV59 | 1.3 | 98.7 | 2.4 | 4.9 | 6.3 |